Related Articles
Is B a Key to Autoimmune Therapy?: B Cell-Targeted Therapies in Autoimmune Disease
A perspective on B cell–targeted therapies in autoimmune disease
T Cells in Systemic Lupus Erythematosus
Progress toward targeted therapy
Cellular Therapy of Autoimmune Disease
Is a novel treatment breakthrough on the horizon?
Researchers Test Belimumab in Scleroderma
A yearlong pilot study that evaluated the safety and efficacy of belimumab in a small group of patients with early diffuse systemic sclerosis found no significant difference in the number of adverse events between those treated with the drug and those who received a placebo. Currently, no drugs are approved specifically for the treatment of…